Medical Condition News

RSS

Bioniche's achievement of fourth milestone in Urocidin Phase III trial triggers $4.0M payment from Endo

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced achievement of a US$4.0 million milestone payment from its development partner, Endo Pharmaceuticals Inc. This milestone is the fourth achieved by Bioniche subsequent to the parties executing their agreement in July, 2009.

18 Nov 2010

EDP Biotech introduces new blood test for detecting early-stage colon cancer at Medica trade fair

The future of colon cancer screening may be surprisingly simple. ColoMarker, an innovative blood test to detect the early stages of colon cancer is generating plenty of attention from a wide audience, including from some of the world's leading researchers in cancer biomarkers and gastrointestinal medicine.

18 Nov 2010

Idera presents data on TLR7, TLR9 antagonist candidate for hyperlipidemia at American Heart Association

Idera Pharmaceuticals, Inc. announced today that it is presenting preclinical data from a study evaluating the mechanism of action of one of its Toll-like receptor (TLR) 7 and TLR9 antagonist candidates in a model of hyperlipidemia.

18 Nov 2010

Researchers are revolutionizing treatment of cardiovascular disease through regenerative stem cell therapy

Northwestern Medicine physician researchers are revolutionizing treatment of cardiovascular disease by utilizing patients' own stem cells to regenerate heart and vascular tissue.

18 Nov 2010

Regado presents poster on REG3 at AHA Scientific Sessions meeting

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and Chief Medical Officer, and Chris Rusconi, Ph.D., Senior Vice President and Chief Scientific Officer, presented a poster about REG3 at the AHA Scientific Sessions meeting.

18 Nov 2010

VX-770 drug candidate improves lung function in people with cystic fibrosis

In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.

18 Nov 2010

Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases

The Krieger Eye Institute at Sinai Hospital opened a new center for the treatment of retinal diseases in November. The retina is the layer of tissue at the back of the eye that converts images to electrical impulses. These electrical signals are then perceived by the brain as sight.

18 Nov 2010

U-Systems initiates EASY study for screening breast cancer

U-Systems, the leader in Automated Breast Ultrasound technology announced participant enrollment has begun in the European Asymptomatic Screening Study (EASY) at Capio Saint Göran Hospital, in Stockholm, Sweden.

18 Nov 2010

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

Sangamo BioSciences, Inc. announced today the presentation of Phase 2 clinical data from its ZFP Therapeutic program to develop SB-509, a zinc finger protein transcriptional activator (ZFP-TF) of the vascular endothelial growth factor (VEGF)-A gene as a treatment for ALS.

17 Nov 2010

New findings suggest novel approach to targeted treatment of cancer

New research that provides potential for exciting new approaches to targeting diseases such as cancer has been announced by an international team of academics.

17 Nov 2010

New investigational drug improves lung function in CF patients

An investigational drug targeting a defective protein that causes cystic fibrosis has been shown to improve lung function in a small study of CF patients, according to findings published Nov. 18, 2010, in the New England Journal of Medicine.

17 Nov 2010

Asbestos problem in NSW needs government attention: Report

A report from the NSW Ombudsman says that the state government is failing to deal with the deadly issue of asbestos despite repeated warnings regarding “immense” amounts of the dangerous material still scattered across NSW.

17 Nov 2010

Low back pain care initiated with chiropractic doctor saves 40% on health care costs

A new study finds that low back pain care initiated with a doctor of chiropractic (DC) saves 40% on health care costs when compared with care initiated through a medical doctor (MD), the American Chiropractic Association (ACA) announced today. The study, featuring data from 85,000 Blue Cross Blue Shield beneficiaries, concludes that insurance companies that restrict access to chiropractors for low back pain treatment may inadvertently pay more for care than they would if they removed such restrictions.

17 Nov 2010

Study on intention-behaviour gap in relation to healthy eating

We regularly hear how the best of intentions do not translate into action. This is nowhere more apparent than in the case of healthy eating, where many fall through the gap between intention and action. Research is ongoing at Teagasc Food Research Centre, Ashtown, and University College Cork to try to decipher this intention-behaviour gap in relation to healthy eating.

17 Nov 2010

13-hour lifesaving heart/liver transplant performed on pulmonary atresia patient

A 28-year old man from Georgia, David Krech, is recovering from a rare, lifesaving heart/liver transplant on October 15 at the University of Maryland Medical Center. The 13-hour operation followed a five-month journey as he awaited a suitable heart and liver donor.

17 Nov 2010

Study reveals very high cumulative estimated effective doses to patients undergoing MPI

Multiple testing with the cardiac diagnostic imaging technique of myocardial perfusion imaging is common, and in many patients is associated with a high cumulative estimated radiation dose, according to a study in the November 17 issue of JAMA.

17 Nov 2010

Scientists investigate new class of drugs for treating kidney failure

Scientists are learning more about how protein gets in the urine when the kidneys begin to fail and how a new drug blocks it.

17 Nov 2010

Health professionals invited for 1st Asia-Pacific Osteoporosis Meeting

Healthcare providers in the Asia-Pacific region are coping with a rising tide of osteoporotic fractures. The IOF Regionals - 1st Asia- Pacific Osteoporosis Meeting, to take place in Singapore from December 10-13, 2010, is an ideal opportunity for health professionals in the region to acquire the latest practical information on osteoporosis and related fractures.

17 Nov 2010

St. Jude organizes tobacco cessation program for cancer survivors who smoke

Cancer survivors who smoke and need help quitting can receive help through a tobacco cessation program organized by St. Jude Children's Research Hospital.

17 Nov 2010

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Rolling back suggestions from previous studies, a Johns Hopkins study of 950 healthy men and women has shown that taking daily doses of a cholesterol-lowering statin medication to protect coronary arteries and ward off heart attack or stroke may not be needed for everyone.

17 Nov 2010

Medical Condition News

Bioniche's achievement of fourth milestone in Urocidin Phase III trial triggers $4.0M payment from Endo

EDP Biotech introduces new blood test for detecting early-stage colon cancer at Medica trade fair

Idera presents data on TLR7, TLR9 antagonist candidate for hyperlipidemia at American Heart Association

Researchers are revolutionizing treatment of cardiovascular disease through regenerative stem cell therapy

Regado presents poster on REG3 at AHA Scientific Sessions meeting

VX-770 drug candidate improves lung function in people with cystic fibrosis

Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases

U-Systems initiates EASY study for screening breast cancer

Sangamo presents Phase 2 clinical data in ALS at Society for Neuroscience Meeting

New findings suggest novel approach to targeted treatment of cancer

New investigational drug improves lung function in CF patients

Asbestos problem in NSW needs government attention: Report

Low back pain care initiated with chiropractic doctor saves 40% on health care costs

Study on intention-behaviour gap in relation to healthy eating

13-hour lifesaving heart/liver transplant performed on pulmonary atresia patient

Study reveals very high cumulative estimated effective doses to patients undergoing MPI

Scientists investigate new class of drugs for treating kidney failure

Health professionals invited for 1st Asia-Pacific Osteoporosis Meeting

St. Jude organizes tobacco cessation program for cancer survivors who smoke

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News